Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects

NCT02173678 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: COMBIVENT® HFA-MDI
DRUG: COMBIVENT® CFC-MDI
DRUG: Placebo HFA-MDI

Sponsor

Boehringer Ingelheim